Table I.
Stimulus | Primary thymocytes | Splenic B cells | Splenic T cells | Bone marrow granulocytes | SV40-immortalized MEFs | Primary MEFs |
Etoposide | 1 µg/ml | 1 µg/ml | 1 µg/ml | 1–10 µg/ml | 10 – 50 µg/ml | 10–50 µg/ml |
Doxorubicin | 400 ng/ml | 400 ng/ml | 400 ng/ml | 400 ng/ml | ND | ND |
Cisplatin | 25–100 µM | 50 µM | 50 µM | 50 µM | 20 µM | ND |
Staurosporine | 100 and 500 nM | 100 nM | 100 nM | 100 and 500 nM | 50 nM | ND |
Ionomycin | 1 µg/ml | ND | ND | ND | ND | ND |
PMA | 10 ng/ml | ND | ND | ND | ND | ND |
Velcade | 50 ng/ml | 50 ng/ml | 50 ng/ml | ND | ND | ND |
Trichostatin A | 50 nM | 50 nM | 50 nM | ND | ND | ND |
Dexamethasone | 10−7 M | 10−7 M | 10−7 M | ND | ND | ND |
TNF-α | 10 ng/ml | 10 ng/ml | 10 ng/ml | 10 ng/ml | 30 ng/ml | ND |
Cycloheximide | 5 µg/ml | 5 µg/ml | 5 µg/ml | 5 µg/ml | 5 µg/ml | ND |
Super Fas ligand | 10 ng/ml | 10 ng/ml | 10 ng/ml | 10 ng/ml | ND | ND |
Cytochalasin D | 2 µM | ND | ND | ND | 20 µM | 20 µM |
Taxol | 500 µM | ND | ND | ND | 100 µM | 100 µM |
Vincristine | ND | ND | ND | ND | ND | 50 µg/ml |
Tunicamycin | 0.1–5 µg/ml | 1 µg/ml | 1 µg/ml | ND | 1.2 µg/ml | ND |
Brefeldin A | 1.25 and 2.5 µg/ml | ND | ND | ND | 1 µg/ml | ND |
Thapsigargin | 0.05–0.1 µg/ml | ND | ND | ND | 50 µg/ml | 50 µg/ml |